Symposium will explore science's next great ideas

September 18, 2006

DURHAM, N.C. -- Three Nobel Prize winners and 10 other leading scientists will come to Duke Medicine's 75th Anniversary Science Symposium on Monday and Tuesday, Sept. 25-26, to share their thoughts on where the next major scientific discoveries will come from and how they may change the future of medicine.

Symposium activities will take place on the Duke University campus at the Searle Center and the Schiciano Auditorium in the Fitzpatrick Center for Interdisciplinary Engineering, Medicine and Applied Sciences Building.

The symposium is open to the public and is free, but people must preregister to attend.

Paul Nurse, an expert on cancer and cell biology who shared the 2001 Nobel Prize in Physiology or Medicine for his research on the regulation of the cell cycle, will give the opening keynote lecture. He is president of Rockefeller University in New York. The lecture will begin at 4 p.m. on Sept. 25 at the Searle Center.

Linda Buck, who shared the 2004 Nobel Prize in Physiology or Medicine for her discoveries about the sense of smell, will open the second day with a plenary lecture. She is a Howard Hughes Medical Institute investigator and researcher at the Fred Hutchinson Cancer Research Center in Seattle. The lecture will begin at 8:30 a.m. on Sept. 26 at the Searle Center.

Joseph Goldstein, who won the 1985 Nobel Prize in Physiology or Medicine for his research on cholesterol metabolism, will give a final plenary lecture, "How to Solve a Scientific Puzzle: Clues from Broadway to Stockholm." He is professor and chair of molecular genetics at the University of Texas Southwestern Medical Center at Dallas (UT Southwestern). The lecture will begin at 2 p.m. on Sept. 26 at the Searle Center.

Symposium co-organizer Peter Agre, vice chancellor for science and technology at Duke, says, "At its most fundamental, scientific inquiry is undertaken to advance knowledge, and you never know what you might learn.

"Advances in basic knowledge also lay the groundwork for advancing medicine, perhaps by revealing a potential weakness in a difficult-to-treat disease or by uncovering how a person's genes influence his or her risk of illness," says Agre, who shared the 2003 Nobel Prize in Chemistry for his laboratory's serendipitous discovery of the family of proteins that transport water into and out of cells. "For example, the protein family we discovered is now known to be involved in certain disorders of the lung, kidney, eye, brain and other organs."

Following the first day's plenary lecture, the 10 invited scientists will speak at five concurrent sessions. The speakers are Bruce Alberts of the University of California at San Francisco and formerly president of the National Academy of Sciences, Carol Greider of the Johns Hopkins University School of Medicine, Helen Hobbs of UT Southwestern, Richard Lifton of the Yale University School of Medicine, Steven McKnight of UT Southwestern, Eric Olson of UT Southwestern, Solomon Snyder of the Johns Hopkins University School of Medicine, Thomas Steitz of Yale University, Bruce Stilllman of Cold Spring Harbor Laboratory in New York, and Christopher Walsh of Harvard Medical School.

People who want to register for the symposium or get a detailed schedule of events should go to http://science.medschool.duke.edu/.
-end-


Duke University Medical Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.